|
PSYCHIATRIC COMORBIDITY: IMPLICATIONS FOR DIAGNOSIS AND TREATMENT
COMORBIDITY IN PSYCHIATRY Chair: Miroslava Jasovic-Gasic Co-chair: Norman Sartorius
09:00-9:20 Norman Sartorius, Switzerland: Comorbidity of mental disorders and somatic illnesses: the main challenge for health services at the beginning of the 21st century 09:20-9:40 Nick Bouras, UK: Explanations of psychiatric comorbidity based on the nature of psychopathology 09:40-10:00 Miro Jakovljevic, Croatia: The four perspectives model, integrative psychiatry and comorbidity 10:00-10:20 Slobodan Loga, Bosnia&Herzegovina: Conceptual approaches to comorbidity in psychiatry: their impact on psychopharmacological decision 10:20-10:30 DISCUSSION SCHIZOPHRENIA AND BIPOLAR DISORDER Chair: Miro Jakovljevic Co-chair: Slobodan Loga 10:45-11:05 Cyril Hoschl, Czech Republic: Discrete and continuous approaches in the conceptualization of schizophrenia and bipolar disorder 11:05-11:25 Lilijana Oruc, Bosnia&Herzegovina: The impact of genetic findings on psychiatric nosology of schizophrenia and bipolar disorders 11:25-11:45 Miroslava Jasovic-Gasic, Serbia: Comorbidity in bipolar disorder: Diagnostical, clinical and therapeutical implications 11:45-12:05 Aleksandar Damjanovic, Serbia: Specificity of comorbidity of schizophrenia and cancer: Treatment recommendations 12:05-12:15 DISCUSSION
13:00-14:00 Remission and recovery in SCH- three steps forward (SS1, P F I Z E R) Miroslava Jašović Gašić: Defining remission and recovery in SCH Slavica Djukić Dejanović: Limitations and barriers in achieving remission and recovery in SCH Aleksandar Damjanović: Evidence based data in achieving remission and recovery - ziprasidon DEPRESSION&ANXIETY&PERSONALITY Chair: Dragan Svrakic Co-chair: Wolfgang Maier
15:00-15:20 Siegfried Kasper, Austria: Comorbidity of OCD and anxiety disorders – implications for treatment 15:20-15:40 Wolfgang Maier, Germany: Derpession in the context of somatic disorders in the elderly 15:40-16:00 Peter Gaszner, Hungary: Psychiatric comorbidity and depressive disorders -implications for the treatment 16:00-16:20 Dragan Svrakic, USA: Are personality factors representing predisposing factor or a co-existing syndrome in people with drug addiction?
16:20-16:30 DISCUSSION DEPRESSION&ANXIETY&PERSONALITY (cont’d) Chair: Nikola Ilankovic Co-chair: Zeljko Spiric 17:30-17:50 Olivera Zikic,et al, Serbia: Depersonalization and suicidality in unipolar depression 17:50-18:10 Gordana Mandic-Gajic & Zeljko Spiric, Serbia: The course and severity of secondary depression among alcocholics during early abstinence 18:10-18:30 Suzana Tosic-Golubovic, et al, Serbia: Diagnostic and demographic correlates of substance abuse among schizophrenic spectrum patients 18:30-19:00 DISCUSSION DEPRESSION&ANXIETY&PERSONALITY (cont’d) Chair: Lilijana Oruc Co-chair: Aleksandar Damjanovic 09:00-09:15 In memoriam (A. Marusic, Slovenia: Psychiatry without depression: A no man's land?) 09:15-09:35 Abdulah Kucukalic & Alma Džubur-Kulenović, Bosnia&Herzegovina: "Psychiatric and somatic comorbidity of PTSD"
09:35-09:55 Milan Latas, Serbia: Comorbidity of panic disorder, agoraphobia and personality disorders - implications for the treatment outcome 09:55-10:15 Antoni Novotni, et al, FYROM: Comorbidity of depression and anxiety disorders 10:1510:30 DISCUSSION
INTERDICIPLINARY Chair: Vladimir Kostic Co-chair: Miroslava Jasovic-Gasic 10:45-11:05 Hans-Jürgen Möller, Germany: Effectiveness studies: do they give better information than phase III studies?
11:05-11:25 Vladimir Kostic, Serbia: Parkinson's disease as a neuropsychiatric disorder - genetics, clinical phenotypes and neuropathology 11:25-11:45 Vera Popovic, Serbia: Mend the mind but mind the bones: Central regulation of bone remodeling 11:45-12:05 Nikola Ilankovic, Serbia: Comorbidity or etiology - the real causes of some mental disorders 12:05-12:15 DISCUSSION 13:00-14:00 SCHIZOPHRENIA, LONG TERM CHALLENGE - ARE WE CLOSE TO SOLUTION? (SS2, JANSSEN)
Moderator: M Jašović-Gašić
Miroslava Jašović-Gašić: Assuring adherence as the most important factor for successful treatment Slavica Djukić-Dejanović: Pharmacoeconomy of schizophrenia - can we measure it in Serbia Aleksandar Damjanovic: Rispolept Consta - sharing our successful Serbian multicentric experience |
